2026 ICD-10-CM Diagnosis Code E79.82Hereditary xanthinuria
ICD-10-CM Codes›E00–E89›E70-E88›E79
- Billable — Valid for Submission
- Chronic Condition
E79.82 is a billable ICD-10-CM diagnosis code for hereditary xanthinuria. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Combined molybdoflavoprotein enzyme deficiency
- Deficiency of xanthine oxidase
- Hereditary xanthinuria
- Hereditary xanthinuria type 1
- Molybdenum cofactor deficiency complementation group A
- Molybdenum cofactor deficiency complementation group B
- Molybdenum cofactor deficiency complementation group C
- Xanthinuria
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Calculus, calculi, calculous
- xanthine - E79.82
- Xanthinuria, hereditary - E79.82
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Calculus, calculi, calculous
- xanthine
- Stone(s)
- xanthine
- Xanthinuria, hereditary
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Code History & ChangesHistory
Replacement E79.82 replaces the following previously assigned code(s):
- E79.8 - Other disorders of purine and pyrimidine metabolism
Questions About E79.82Overview
Is E79.82 (Other disorders of purine and pyrimidine metabolism) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report hereditary xanthinuria on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
